Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Immunic | IMUX | May 22, 2024 | 1.27 | 0.00 |
ImmunityBio | IBRX | May 22, 2024 | 6.94 | +1.98 |
Immunocore ADR | IMCR | May 22, 2024 | 50.47 | -1.04 |
Immunome | IMNM | May 22, 2024 | 14.42 | +5.64 |
ImmunoPrecise Antibodies | IPA | May 22, 2024 | 1.17 | +3.70 |
Immunovant | IMVT | May 22, 2024 | 29.56 | -2.44 |
Immutep ADR | IMMP | May 22, 2024 | 3.12 | -3.41 |
Imperial Oil | IMO | May 22, 2024 | 68.04 | -2.21 |
Imperial Petroleum | IMPP | May 22, 2024 | 4.35 | +3.82 |
Imperial Petroleum A Pref | IMPPP | May 22, 2024 | 24.50 | +0.14 |
Impinj | PI | May 22, 2024 | 173.33 | +3.33 |
Imunon | IMNN | May 22, 2024 | 1.42 | 0.00 |
IN8bio | INAB | May 22, 2024 | 1.05 | +3.96 |
Inari Medical | NARI | May 22, 2024 | 47.67 | +4.27 |
Incannex Healthcare ADR | IXHL | May 22, 2024 | 2.69 | +0.37 |
Inception Growth Acquisition | IGTA | May 22, 2024 | 11.15 | +0.04 |
Inception Growth Acquisition Unit | IGTAU | May 22, 2024 | 11.35 | 0.00 |
Income Opportunity Realty Investors | IOR | May 22, 2024 | 16.23 | +1.12 |
Incyte | INCY | May 22, 2024 | 58.20 | +1.39 |
Indaptus Therapeutics | INDP | May 22, 2024 | 2.48 | +5.53 |
Independence Contract Drilling | ICD | May 22, 2024 | 1.54 | +0.65 |
Independence Realty Trust | IRT | May 22, 2024 | 16.95 | -0.47 |
Independent Bank | IBCP | May 22, 2024 | 26.03 | -0.91 |
Independent Bank | INDB | May 22, 2024 | 54.06 | +1.64 |
Independent Bank Group | IBTX | May 22, 2024 | 46.67 | -0.32 |
India Bull 3X Direxion | INDL | May 22, 2024 | 65.28 | +0.26 |
India Consumer Egshares | INCO | May 22, 2024 | 66.39 | +0.40 |
India Earnings Wisdomtree | EPI | May 22, 2024 | 46.17 | +0.13 |
India Fund | IFN | May 22, 2024 | 17.93 | -0.11 |
India Powershares | PIN | May 22, 2024 | 27.78 | +0.18 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.